» Articles » PMID: 36367481

CRISPR-Cas-based Techniques for Pathogen Detection: Retrospect, Recent Advances, and Future Perspectives

Overview
Journal J Adv Res
Date 2022 Nov 11
PMID 36367481
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early detection of pathogen-associated diseases are critical for effective treatment. Rapid, specific, sensitive, and cost-effective diagnostic technologies continue to be challenging to develop. The current gold standard for pathogen detection, polymerase chain reaction technology, has limitations such as long operational cycles, high cost, and high technician and instrumentation requirements.

Aim Of Review: This review examines and highlights the technical advancements of CRISPR-Cas in pathogen detection and provides an outlook for future development, multi-application scenarios, and clinical translation.

Key Scientific Concepts Of Review: Approaches enabling clinical detection of pathogen nucleic acids that are highly sensitive, specific, cheap, and portable are necessary. CRISPR-Cas9 specificity in targeting nucleic acids and "collateral cleavage" activity of CRISPR-Cas12/Cas13/Cas14 show significant promise in nucleic acid detection technology. These methods have a high specificity, versatility, and rapid detection cycle. In this paper, CRISPR-Cas-based detection methods are discussed in depth. Although CRISPR-Cas-mediated pathogen diagnostic solutions face challenges, their powerful capabilities will pave the way for ideal diagnostic tools.

Citing Articles

CRISPR in clinical diagnostics: bridging the gap between research and practice.

Lafi Z, Ata T, Asha S Bioanalysis. 2025; 17(4):281-290.

PMID: 39902531 PMC: 11866644. DOI: 10.1080/17576180.2025.2459520.


Developing a Versatile Arsenal: Novel Antimicrobials as Offensive Tools Against Pathogenic Bacteria.

Ma J, Lu Z Microorganisms. 2025; 13(1).

PMID: 39858940 PMC: 11767912. DOI: 10.3390/microorganisms13010172.


CRISPR/Cas system and its application in the diagnosis of animal infectious diseases.

Rasool H, Chen Q, Gong X, Zhou J FASEB J. 2024; 38(24):e70252.

PMID: 39726403 PMC: 11671863. DOI: 10.1096/fj.202401569R.


Recent Advances in CRISPR/Cas System-Based Biosensors for the Detection of Foodborne Pathogenic Microorganisms.

Xie S, Yue Y, Yang F Micromachines (Basel). 2024; 15(11).

PMID: 39597141 PMC: 11596558. DOI: 10.3390/mi15111329.


A rapid visualization method for detecting rotavirus A by combining nuclear acid sequence-based amplification with the CRISPR-Cas12a assay.

Chen Y, Wu J, Gao E, Lu Y, Qiu H J Med Microbiol. 2024; 73(10).

PMID: 39360804 PMC: 11448473. DOI: 10.1099/jmm.0.001892.


References
1.
Guk K, Keem J, Hwang S, Kim H, Kang T, Lim E . A facile, rapid and sensitive detection of MRSA using a CRISPR-mediated DNA FISH method, antibody-like dCas9/sgRNA complex. Biosens Bioelectron. 2017; 95:67-71. DOI: 10.1016/j.bios.2017.04.016. View

2.
Wang J, Wu L, Ren J, Qu X . Visualizing human telomerase activity with primer-modified Au nanoparticles. Small. 2011; 8(2):259-64. DOI: 10.1002/smll.201101938. View

3.
Chang W, Liu W, Liu Y, Zhan F, Chen H, Lei H . Colorimetric detection of nucleic acid sequences in plant pathogens based on CRISPR/Cas9 triggered signal amplification. Mikrochim Acta. 2019; 186(4):243. DOI: 10.1007/s00604-019-3348-2. View

4.
Wei Y, Yang Z, Zong C, Wang B, Ge X, Tan X . trans Single-Stranded DNA Cleavage via CRISPR/Cas14a1 Activated by Target RNA without Destruction. Angew Chem Int Ed Engl. 2021; 60(45):24241-24247. DOI: 10.1002/anie.202110384. View

5.
Xiang Y, Zhu X, Huang Q, Zheng J, Fu W . Real-time monitoring of mycobacterium genomic DNA with target-primed rolling circle amplification by a Au nanoparticle-embedded SPR biosensor. Biosens Bioelectron. 2014; 66:512-9. DOI: 10.1016/j.bios.2014.11.021. View